Grzegorz S Nowakowski, MD

  • 3872 Citations
  • 38 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Grzegorz S Nowakowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 33 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Survival Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 3872 Citations
  • 38 Scopus h-Index
  • 120 Article
  • 7 Review article
  • 3 Letter
  • 1 Comment/debate
3 Citations (Scopus)

AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., Pinto, A., Re, F., Fogliatto, L. M., Scheinberg, P., Flinn, I. W., Moreira, C., Cabeçadas, J., Liu, D., Kalambakas, S., Fustier, P. & 2 othersWu, C. & Gribben, J. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1188-1199 12 p.

Research output: Contribution to journalArticle

Open Access
Lymphoma
Placebos
Neutropenia
Disease-Free Survival
lenalidomide
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival

End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma

Kostakoglu, L. & Nowakowski, G. S., Jul 1 2019, In : PET Clinics. 14, 3, p. 307-315 9 p.

Research output: Contribution to journalReview article

Lymphoma, Large B-Cell, Diffuse
tomography
Tomography
Disease-Free Survival
progressions

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

Nowakowski, G. S., Feldman, T., Rimsza, L., Westin, J. R., Witzig, T. E. & Zinzani, P. L., Jun 1 2019, In : Blood cancer journal. 9, 6, 48.

Research output: Contribution to journalReview article

Open Access
Precision Medicine
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Therapeutics
Germinal Center
4 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio